Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Neostigmine Dose Comparison for Diaphragmatic Dynamics in Laparoscopic Cholecystectomy
NCT06787638Phase 1Not yet recruiting
- Sponsor
- Aswan University Hospital
- Start
- Jan 2025
- Primary completion
- Jan 2026
- Modality
- Small Molecules
01
Overview
Phase 1, randomised trial of neostigmine in neuromuscular blockade (NMB) (2 arms), sponsored by Aswan University Hospital. Primary endpoint: Diaphragmatic Dynamics. Planned start Jan 2025; status: not yet recruiting.
02
Drugs
neostigmine
03
Conditions
neuromuscular blockade (NMB)
Beyond the preview
Go deeper on NCT06787638.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06787638.